Evelien J.M. de Jong

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Judith de Vos‐Geelen · 3 shared papers, 2022–2025 · strength 0.53
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
2. Johanna W. Wilmink · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
3. Stefan A.W. Bouwense · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
4. Vincent Erwin de Meijer · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
5. Hanneke W.M. van Laarhoven · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
6. Lydia G. van der Geest · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
7. Marc G. Besselink · 2 shared papers, 2022–2025 · strength 0.34
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
8. Bas Groot Koerkamp · 2 shared papers, 2022–2025 · strength 0.32
   • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
   • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
9. Lois A. Daamen · 1 shared paper, 2025 · strength 0.21
   • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
10. Izaak Quintus Molenaar · 1 shared paper, 2025 · strength 0.21
    • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
11. Merlijn U.J.E. Graus · 1 shared paper, 2025 · strength 0.21
    • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
12. Ignace H. J. T. de Hingh · 1 shared paper, 2025 · strength 0.21
    • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
13. Aniek E. van Diepen · 1 shared paper, 2025 · strength 0.21
    • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
14. Martijn W.J. Stommel · 1 shared paper, 2025 · strength 0.21
    • Paper Patterns of disease dissemination and survival in patients with synchronous and metachronous metastatic pancreatic aden… DOI 10.1016/j.ejca.2025.115385↗
15. Xiuxiang Tan · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
16. Lara Rosaline Heij · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
17. Edgar Dahl · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
18. Michail Doukas · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
19. Georg J. Wiltberger · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
20. Wolfram Trudo Knoefel · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
21. Casper H.J. van Eijck · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
22. Tom Luedde · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
23. Shivan Sivakumar · 1 shared paper, 2025 · strength 0.19
    • Paper Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer. DOI 10.1038/s41598-025-94362-x↗
24. Quisette P. Janssen · 1 shared paper, 2022 · strength 0.13
    • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗
25. Bert A. Bonsing · 1 shared paper, 2022 · strength 0.13
    • Paper Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocar… DOI 10.1002/ijc.33916↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.